Streptococcal protein SIC activates monocytes and induces inflammation

Area of Science:

• Immunology
• Microbiology
• Molecular Biology

Background:

• Streptococcus pyogenes is a significant human pathogen.
• The M1 serotype secretes Streptococcal inhibitor of complement (SIC), which impedes innate immunity.
• M1 serotype infections often involve severe inflammation.

Purpose of the Study:

• To investigate the mechanism by which SIC from M1 S. pyogenes interacts with human immune cells.
• To determine the role of SIC in monocyte activation and pro-inflammatory cytokine release.
• To explore the influence of plasma proteins on SIC-mediated monocyte activation.

Main Methods:

• Monocyte activation assays using SIC from M1 and M55 serotypes.
• Analysis of signaling pathways (NF-κB, p38 MAPK) and cytokine release (TNFα, INFγ).
• Investigation of SIC binding to plasma proteins (clusterin, histidine-rich glycoprotein).

Main Results:

• M1 SIC interacts with TLR2 and CD14 on monocytes, activating NF-κB and p38 MAPK pathways.
• SIC induces the release of pro-inflammatory cytokines TNFα and INFγ.
• Clusterin and histidine-rich glycoprotein in human plasma enhance SIC-mediated monocyte activation.

Conclusions:

• SIC from M1 S. pyogenes possesses pro-inflammatory properties by activating monocytes.
• The interaction with plasma proteins amplifies SIC's effect on monocytes.
• SIC likely contributes to the pathology of invasive S. pyogenes infections characterized by inflammation.